Home > Newsletters > The QMN Weekly Bulletin > Reports of Opioid Overfills Continue to Bedevil Hospira, Prompting Fresh Recall
The QMN Weekly Bulletin
Aug. 17, 2012 | Vol. 4 No. 33
Reports of Opioid Overfills Continue to Bedevil Hospira, Prompting Fresh Recall
Hospira is recalling another lot of hydromorphone HCl injection after receiving fresh reports of overfills in the syringe-based drug delivery system. The Schedule II substance comes in a prefilled glass cartridge for use with the 2.5-mL carpuject device. But the affected product reportedly contains more than the 1-mL labeled fill volume. No adverse events have been reported due to overfills of the affected lot, which was distributed between March and May, Hospira said late Wednesday.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.